TP53 and neuroblastoma: Further studies would provide valuable knowledge regarding the mechanisms through which p53 loss mediates drug-resistance in NB, potential strategies to attack this problem, and crucial information regarding the mechanisms of action, spectrum of in-vivo efficacy, and basic pharmacology of didymin.